Nemec Sarah's Form 4 filing
Bolt Biotherapeutics, Inc. (BOLT) · filed Sep 21, 2026
- Accession no.
- 0001193125-26-396892
- Filed
- Sep 21, 2026, 6:04 PM ET
- Trade date
- Jun 5-Sep 18, 2026
- Filing delay
- 108 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market purchases total $1.97K. Open-market sales total $26.1K. It was filed 108 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Nemec SarahCIK 0002023538 | Officer (Senior VP, Finance and PAO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | Common Stock | PPurchaseAcquired | +509 | $3.88 | +$1,972.88 | 1,924 | Direct | |
| Sep 16, 2026 | Common Stock | SSaleDisposed | −843 | $3.77F2 | −$3,181.48 | 24,081 | Direct | |
| Sep 17, 2026 | Common Stock | SSaleDisposed | −2,922 | $3.32F3 | −$9,696.07 | 21,159 | Direct | |
| Sep 18, 2026 | Common Stock | SSaleDisposed | −4,077 | $3.24F4 | −$13,194.8 | 17,082 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents weighted average sales price. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units granted on October 22, 2025. The shares were sold at prices ranging from $3.60 to $4.14. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the "SEC"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents weighted average sales price. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units granted on October 22, 2025. The shares were sold at prices ranging from $3.22 to $3.67. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the "SEC"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents weighted average sales price. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units granted on October 22, 2025. The shares were sold at prices ranging from $3.15 to $3.41. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the "SEC"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.